Oriomics Launches XiaoWeiAn Multi-Tumor Early Screening Product
Hangzhou Ao’rui Biological Technology Co., Ltd (Oriomics) announced the market launch of XiaoWeiAn, a multi-tumor...
Hangzhou Ao’rui Biological Technology Co., Ltd (Oriomics) announced the market launch of XiaoWeiAn, a multi-tumor...
China-based Joysbio (Tianjin) Biotechnology Co., Ltd. has developed a rapid test to diagnose the latest...
The National Medical Products Administration (NMPA) has approved two innovative medical devices in China: Ningbo...
Venus Medtech (Hangzhou) Inc. (HKG: 2500) announced the first compassionate use of its VenusP-Valve, a...
China-based Grand Pharmaceutical Group Limited (HKG: 0512) has announced the official launch of its SIR-Spheres...
China-based Qingdao HuaRen Pharmaceutical Co., Ltd (SHE: 300110) has announced receiving CE marks in the...
US-based Boston Scientific Corporation (NYSE: BSX) has announced the official market launch of its Expect...
The National Medical Products Administration (NMPA) approved a total of 164 medical devices for marketing...
Shanghai MicroPort MedBot (Group) Co., Ltd (HKG: 2252) announced the successful completion of a remote...
Shanghai Roche Pharmaceuticals Ltd. made headlines in March with the launch of its lung cancer...